Quick Answer
NEOGENOMICS INC reported Gross Profit of $314.29 million for fiscal year 2025.
NEOGENOMICS INC Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $314.29M | +8.3% |
| 2024 | $290.10M | +18.6% |
| 2023 | $244.60M | +30.2% |
| 2022 | $187.90M | +0.4% |
| 2021 | $187.06M | +0.6% |
| 2020 | $185.89M | -5.6% |
| 2019 | $196.84M | +54.7% |
| 2018 | $127.27M | +24.8% |
| 2017 | $101.96M | +3.9% |
| 2016 | $98.10M | +124.2% |
| 2015 | $43.76M | +7.5% |
| 2014 | $40.71M | +28.3% |
| 2013 | $31.74M | +18.3% |
| 2012 | $26.84M | +38.1% |
| 2011 | $19.43M | +23.1% |
| 2010 | $15.78M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $80.45M | +7.4% | +4.1% |
| June 30, 2025 | $77.26M | +6.6% | +5.5% |
| March 31, 2025 | $73.25M | +11.9% | -2.2% |
| September 30, 2024 | $74.88M | +20.2% | +3.3% |
| June 30, 2024 | $72.49M | +21.0% | +10.7% |
| March 31, 2024 | $65.47M | +19.4% | +5.1% |
| September 30, 2023 | $62.31M | +27.4% | +4.0% |
| June 30, 2023 | $59.89M | +36.3% | +9.3% |
- NEOGENOMICS INC showed an increase of +8.3% in Gross Profit compared to the prior fiscal year.
- Over the 2010–2025 period, NEOGENOMICS INC’s gross profit has grown by 1891.3% (from $15.78 million to $314.29 million).
- The most recent figure is from NEOGENOMICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: